Skip to content
Search

Latest Stories

GASTROINTESTINAL: Treating IBS in pharmacy

By Elena Markaryan

Irritable bowel syndrome (IBS) is a common condition, affecting around one in every ten adults. It can cause unpleasant symptoms including abdominal pain, bloating and bowel symptoms. Patients can be constipated (IBS-C), or suffer diarrhoea (IBS-D), or suffer from a mix of both.


It is estimated that approximately one-third of patients with IBS experience diarrhoea as their predominant bowel habit, causing a wide range of unpleasant symptoms, which severely impact their professional and personal lives.

Linked to this, there are approximately 17 million cases of diarrhoea annually in the UK, resulting in a million GP visits which is a significant burden on the NHS. There is an unmet need to reduce duration of symptoms and numbers of GP visits and A&E attendance.

Causes and treatment

Symptoms of IBS can include abdominal pain and cramps, diarrhoea, constipation, alternating constipation and diarrhoea, changes in bowel movements, gas and bloating, food Intolerance – the most common triggers are large meals, spicy food, bread, excessive fibre – especially insoluble fibre – chocolate, alcohol, caffeine, fructose, sorbitol, fizzy drinks, fried and fatty foods.

Prof Yan Yiannakou, Professor of Neurogastroenterology at County Durham and Darlington NHS Foundation Trust, gives some useful insight into the condition: “A proportion of patients (perhaps 10 per cent) with acute infectious gastroenteritis can go on to develop chronic diarrhoea with abdominal pain. The diagnosis usually turns out to be diarrhoea predominant irritable bowel syndrome (IBS-D). It is thought that the cause of this (going from gastroenteritis to IBS-D) might be related to an activated immune system.

“The immune system in the gut becomes activated to fight the infection and should settle down after the infection has cleared. However, in some individuals this doesn’t happen and increased immune cells are present in the lining of the gut. These immune cells produce chemicals which can irritate the gut and cause diarrhoea, or might alter the balance of the bacteria which normally live in the bowel (microbiome). These bacteria are involved in producing the bowel motion and an alteration in this can make the motion too loose (or too hard).”

A bad bout of food poisoning can cause bacterial overgrowth in the small intestine leading to IBS, although the exact cause of IBS is unknown. IBS has been linked to food passing through the gut too slowly or rapidly, stress impacting on the gut, a family history of IBS, or oversensitive nerves in the gut. Some of the treatment options can include oral intestinal adsorbents and loperamide for diarrhoea, Ispaghula Husk for constipation, Hyoscine butyl bromide for cramping.

Advice for pharmacists

Those suffering with IBS can also experience acid reflux. Gastroesophageal reflux disease, or GERD, causes acid reflux, commonly referred to as heartburn and some patients can be unlucky enough to be suffering from both these conditions. Proton pump inhibitors (PPI’s) are regularly prescribed to lower stomach acid for those suffering with indigestion and heartburn and acid reflux.

Pharmacist Daniel Brash comments: “Most patients won’t be aware of the fact that PPIs (e.g. omeprazole, which is very commonly used) alter the gut flora and are associated with increased risk of infections such as gastroenteritis as a result.”

Many people with IBS suffer with chronic diarrhoea. While anti-diarrhoea medication slows down the frequency of bowel movements, the harmful substances that contribute to IBS symptoms remain in the digestive tract. To effectively alleviate the symptoms of IBS related diarrhoea, it’s useful to stock oral intestinal adsorbents, which bind bacterial toxins, immune proteins, fat molecules and bile acids which may contribute to IBS. These substances are then removed from the body with the stool, effectively alleviating symptoms of IBS flare-ups, and reducing stool frequency and duration of diarrhoea. A 20-day treatment course is recommended.

Pharmacy advice for patients

  • Try to eat at about the same time each day to help regulate bowel function.
  • Exercise regularly
  • Try to avoid your food triggers for IBS.
  • Reduce stress as much as possible, as this can be a major trigger – it’s a well-researched contributor to IBS. There’s a strong link between the brain and gut, so think about strategies to keep flare-ups under control. If you feel anxious in the mornings as your symptoms are worse, then make sure your morning routine includes plenty of time to go to the toilet.
  • Diet and lifestyle changes can go a long way to minimise IBS flare-ups, but if sufferers are finding that these changes are not working they can find themselves turning to multiple medications – which often come with unwanted side effects. Instead, pharmacists can suggest innovative, drug-free oral intestinal adsorbents that are proven to alleviate chronic diarrhoea and abdominal pain associated with IBS.

Finally, it’s worth noting that customers may be unaware that IBS is not a dangerous condition, and usually, there is no link to developing further bowel problems. However, pharmacists need to be aware of any potential ‘reg flags’ and know when to refer.

Elena Markaryan is Director of Enteromed

This article also appears in the February issue of Pharmacy Business.

More For You

Samson Akere with the Totty Pharmacy team

Samson Akere with the Totty Pharmacy team

“Team work makes dream work”

Winning Team of the Year at the Pharmacy Business Awards, just one year after opening, is a reflection of the exceptional leadership Totty Pharmacy owner Samson Akere displayed to ensure his first foray into ownership was a success.

Akere took over the pharmacy in Charlton in October 2023 and straight away he set out on the path to create a diverse, multi-skilled team.

Keep ReadingShow less
Humanin Peptide: A Mitochondrial-Derived Factor with Potential Implications for Cellular Research

Humanin Peptide: A Mitochondrial-Derived Factor with Potential Implications for Cellular Research

Humanin is a mitochondrial-derived peptide (MDP) that has garnered interest due to its potential roles in cellular homeostasis, stress resistance, and metabolic regulation. Initially discovered in relation to neuroprotection, this small peptide has since been hypothesized to interact with multiple cellular pathways, suggesting its involvement in broader physiological processes. Given its origin from mitochondrial DNA (mtDNA), Humanin is believed to be a key player in mitochondrial communication with the nucleus and other cellular compartments, potentially impacting various research fields, including cellular aging, metabolic regulation, and cellular stress response.

Molecular Characteristics and Mechanisms

Keep ReadingShow less
The Realities of Dementia Care for Families

The Realities of Dementia Care for Families

Caring for a loved one with dementia is a journey that presents both emotional and practical challenges for families. Dementia, a progressive condition affecting memory, cognition, and behaviour, requires long-term care strategies and significant emotional resilience. Understanding the realities of dementia care can help families prepare and ensure their loved ones receive the best possible support.

1. The Emotional Toll on Families

Keep ReadingShow less
The UK Commission on Pharmacy Professional Leadership’s report outlined three potential pathways for the future of pharmacy leadership
UKPPLAB aims to enable greater collaboration across the pharmacy professional leadership bodies (gettyimages)

Exclusive: Pharmacy leaders have the opportunity to "co-create the future” with greater collaboration

By Sarwar Alam

Pharmacy leaders from across the sector need to work together in order to have a stronger voice in the future of the healthcare system, Sir Hugh Taylor, chair of the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB), has told Pharmacy Business.

Keep ReadingShow less
Pharmacy First: Workforce capacity continues to be a concern
Community pharmacies in England delivered 2 million Pharmacy First consultations in the first year alone (gettyimages)

Pharmacy First needs proper support to reach its full potential: Numark

Sector needs a remuneration model that ensures pharmacies are not just delivering Pharmacy First service, but thriving while doing so 

Pharmacy First has demonstrated the enormous value of community pharmacy in providing accessible front-line care. However, pharmacists continue to face several challenges in delivering the service.

“Pharmacy First is a success, but it needs proper support to reach its full potential,” said Numark chairman Harry McQuillan.

Keep ReadingShow less